Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Pfizer sues Metsera, Novo Nordisk

Digest more
 · 34m · on MSN
Pfizer files second lawsuit against Metsera, Novo Nordisk
Pfizer Inc said on Monday it has filed a second lawsuit against its controlling shareholder, Metsera, and Novo Nordisk in a Delaware federal court, accusing them of anticompetitive conduct. The latest lawsuit follows Danish drugmaker Novo's bold and unsolicited counter-bid for U.

Continue reading

Pharmaceutical Technology · 2h
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war
Axios on MSN · 2d
Pfizer files lawsuit to block Novo Nordisk's bid for Metsera
Yahoo Finance
1h

Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk

NEW YORK, November 03, 2025--(BUSINESS WIRE)--Pfizer Inc. today announced that it has filed a second lawsuit against ...
Fierce Biotech
6h

Pfizer sues Metsera over Novo's shock counteroffer, but obesity biotech stands firm

For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales growth for its blockbuster obesity drug Wegovy, Doustdar has already ...
7h

Novo Nordisk: Desperate Move

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO stock is a buy.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms